Clinical data | |
---|---|
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.039.702 |
Chemical and physical data | |
Formula | C14H12ClN3O3S |
Molar mass | 337.78 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Fenquizone (INN) is a diuretic, part of the class of low-ceiling sulfonamide diuretics. Fenquizone is used primarily in the treatment of oedema and hypertension.
See also
References
- Ferrando C, Foy JM, Pratt CN, Purvis JR (April 1981). "On the pharmacological actions of a diuretic, fenquizone, with particular reference to its site of action". The Journal of Pharmacy and Pharmacology. 33 (4): 219–22. doi:10.1111/j.2042-7158.1981.tb13761.x. PMID 6115903.
- "Fenquizone". Drug Information from MIMS. Thailand.
Diuretics (C03) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Sulfonamides (and etacrynic acid) |
| ||||||||
Potassium-sparing (at CD) |
| ||||||||
Osmotic diuretics (PT, DL) | |||||||||
Vasopressin receptor inhibitors (DCT and CD) | |||||||||
Other | |||||||||
Combination products | |||||||||
|
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |